Navigation Links
Oticon Tapes Out Innovative Hearing-Aid DSP Using Synopsys IC Compiler
Date:6/2/2008

IC Compiler Enables Extremely Low-Power Design for Innovative Medical

Device

MOUNTAIN VIEW, Calif., June 2 /PRNewswire-FirstCall/ -- Synopsys, Inc. (Nasdaq: SNPS), a world leader in software and IP for semiconductor design and manufacturing, today announced that Oticon has taped out part of its next-generation digital signal processor (DSP) chipset for hearing-aid devices using Synopsys' IC Compiler design planning and place-and-route product, which is part of the Eclypse(TM) Low Power Solution. Enhanced design productivity, small form factor, and low power consumption were key requirements for Oticon's design. Oticon leveraged IC Compiler within Synopsys' Pilot Design Environment, delivering predictable low-power results and enabling faster time to tapeout.

"Battery life is one of our customers' major concerns. Taking advantage of IC Compiler's automatic multi-voltage, MTCMOS shutdown, and multi-threshold capabilities, we were able to meet our extreme low-power requirements and deliver new innovation to our hearing aid users," said Mogens Balsby, director of IC Design at Oticon. "Because we were moving to a new, advanced technology node and time-to-market was critical, we used Synopsys' Pilot tapeout-proven design environment, which includes full implementation, formal checking, and physical verification and leverages best-in-class tools. We were extremely satisfied with the results achieved with IC Compiler and the Pilot Design Environment on our complex design."

Oticon is the world leader in the design, development, and manufacture of hearing aids that embed sophisticated integrated circuits (ICs) that deliver massively parallel, digital audio signal processing and wireless commu
'/>"/>

SOURCE Synopsys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Eric Rowinsky, M.D. and Martin Cannon Join Tapestry Board of Directors
2. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
3. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
4. Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference
5. Riverside Partners Teams with Management to Acquire Innovative Product Achievements
6. TriWest Receives National Awards for Innovative Video Communications to Military Community
7. Medsn to Become Indegene Pharmaceutical Solutions, Inc.: Change Signifies the Success of Its Innovative Global Services Model
8. Innovative antennae may signal a new wave in health care provision
9. Beautiful Teeth Not Just for the Dentists Office Anymore / SpaBrite Teeth Whitening System(TM) Introduces Innovative, New Teeth Whitening Experience To Spas
10. Two Michigan Orthopedic Surgeons Pioneer Innovative ACL Surgery with New Benefits for Athletes, Weekend Warriors
11. In blood vessel stents, innovative materials allow better control, delivery of gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/9/2009).../PRNewswire-FirstCall/ - Hard to Treat Diseases (H...ntly completed a merger with Slavica Bio Chem (For... billion shares to pay for the Slavica merger and ...or Slavica is 300 million non-dilatable restricted...lved in Belgrade Serbia research. Key medical cons...
(Date:1/8/2009)...ire/ -- New York City Mayor Michael R. Bloomberg d..." and presented a proclamation to Ilchi Lee, presi...iation) and developer of Brain Education, a revolu...alth, well-being, and mental ability for all ages....ding the power of individuals to change themselves...
(Date:1/8/2009)...e/ -- A study released this week showing that a gr...ple chronic diseases shines a much-needed spotligh... to one that focuses on primary and secondary prev... leader in disease prevention. , , (Logo: h...9LOGO ) , , The study, conducted by Social &a...
(Date:1/8/2009)...enator Daschle at his confirmation hearing to be t... , , WASHINGTON, Jan. 8 /PRNewswire-USNewswire/...member Senator Tom Daschle, nominee for Department...duced by fellow BPC founder and friend Senator Bob...ng was convened by the Senate Health, Education, L...
Breaking Medicine News(10 mins):Health News:Hard To Treat Diseases (HTDS) Recapitalization 2Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4
...gic reaction caused to many human beings. A new Ma...// allergic contact dermatitis. The exact definiti...ammation resulting in swollen, reddened and itchy ...rgen. The ten allergens identified by the mayo st...
...y foods seemed to score less in nutrition value be...nutrients, // like iron and protein. Sales of orga...four babies are growing up on daily helpings of th... appropriate labeling of baby food , came into for...
...a sudden emotional stress could weaken the heart. ...failure// in romance are said to be the triggering...archers at Johns Hopkins University found that sho...that mimic a serious heart attack causing severe h...
...nt officials that the much dreaded bird flu virus ... in UK//. The feral birds have the potential of po...urban areas, as they are susceptible to infection ...exact mechanism of how pigeons contract the infect...
Other Medicine News:
(Date:1/9/2009).../ -- ESBATech AG, a leading developer of antibody ...ion of the Phase I/IIa clinical development of its...arthritis (OA). This double-blind, randomized, pla...gned to investigate the safety, tolerability and e...ntra-articular administration to patients with sev...
(Date:1/8/2009)...wire-FirstCall/ -- , - ThromboGenics, Lead ...acular Adhesion in the US and Europe , Thro...logy company,focused on innovative treatments for...ces today that it has started the Phase III clinic...reatment of back of the eye disease, the,final st...
(Date:1/8/2009)...econd indication with clinical-stage, systemically...ONT, Calif., Jan. 8 Quark Pharmace...company discovering and developing novel RNA inter... that it has initiated patient dosing in its Phase...dministered siRNA drug candidate QPI-1002 (previou...
(Date:1/8/2009)...te Novel Gene Expression Biomarkers Involved in Wo...rm , , FREMONT, Calif., Jan. 8 /PRNewswire-Firs...Board: WGBS), a leading developer of state-of-the-...stem cell research systems, today announced the si...sity of Texas Southwestern Medical Center for the...
Breaking Medicine Technology:ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Media Affects Public Perception of Infectious Diseases 28442 1Media Affects Public Perception of Infectious Diseases 28442 2Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 1Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 2Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 3Natural Hormone Balance 3A Gaining Ground in the Fight Against Breast Cancer 28436 1Natural Hormone Balance 3A Gaining Ground in the Fight Against Breast Cancer 28436 2If metastasectomy should be performed before other treatments 28433 1If metastasectomy should be performed before other treatments 28433 2
...tive lens delivering magnification of 2.0x, 2.5x a...f use. Movement whilst maintaining focal clarity i...The ultra lightweight aluminum bar and individual ...he mounted loupes and optimal focal alignment, eli...
...tive lens delivering magnification of 2.0x, 2.5x a...f use. Movement whilst maintaining focal clarity i...The ultra lightweight aluminum bar and individual ...he mounted loupes and optimal focal alignment, eli...
Utilized for capsulotomies, nucleus dislocating, and other intraocular applications. Formed (bent) cystitomes are angled to conform to the convexity of the lens, providing easier access to the anteri
23 gauge thin wall irrigation. 25 gauge thin wall aspiration. Angled 30 degree shaft 8 mm from tip to bend. Irrigation tip set 0.5 mm behind aspiration tip. Dual hub construction. Polished finish. Ov
Medicine Products: